Matsuda J, Takano H, Imori Y, Ishihara K, Sangen H, Kubota Y, Nakata J, Miyachi H, Hosokawa Y, Tara S, Tokita Y, Yamamoto T, Kitamura M, Takayama M, Asai K (2024) Long-term clinical outcomes after alcohol septal ablation for hypertrophic obstructive cardiomyopathy in Japan: a retrospective study. Heart Vessels. https://doi.org/10.1007/s00380-024-02489-0

Article  PubMed  Google Scholar 

Terauchi Y, Kubo T, Baba Y, Hirota T, Tanioka K, Yamasaki N, Furuno T, Kitaoka H (2015) Gender differences in the clinical features of hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. J Cardiol 65:423–428

Article  PubMed  Google Scholar 

Sedaghat-Hamedani F, Kayvanpour E, Tugrul OF, Lai A, Amr A, Haas J, Proctor T, Ehlermann P, Jensen K, Katus HA, Meder B (2018) Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals. Clin Res Cardiol 107:30–41

Article  PubMed  Google Scholar 

Bi X, Song Y, Yang C, Song Y, Zhao S, Qiao S, Zhang J (2022) Sex differences in atrial remodeling and its relationship with myocardial fibrosis in hypertrophic obstructive cardiomyopathy. Front Cardiovasc Med 9:947975

Article  PubMed  PubMed Central  Google Scholar 

Chen Y-Z, Zhao X-S, Yuan J-S, Zhang Y, Liu W, Qiao S-B (2022) Sex-related differences in left ventricular remodeling and outcome after alcohol septal ablation in hypertrophic obstructive cardiomyopathy: insights from cardiovascular magnetic resonance imaging. Biol Sex Differ 13:37

Article  PubMed  PubMed Central  Google Scholar 

Chen Y-Z, Qiao S-B, Hu F-H, Yuan J-S, Yang W-X, Cui J-G, Zhang Y, Zhang C-L (2015) Left ventricular remodeling and fibrosis: sex differences and relationship with diastolic function in hypertrophic cardiomyopathy. Eur J Radiol 84:1487–1492

Article  PubMed  Google Scholar 

Cui H, Schaff HV, Geske JB, Lahr BD, Dearani JA, Nishimura RA, Ommen SR (2022) Early septal reduction therapy for patients with obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg 164:1502-1509.e5

Article  PubMed  Google Scholar 

Nakashima Y, Kubo T, Sugiura K, Ochi Y, Takahashi A, Baba Y, Hirota T, Yamasaki N, Kimura A, Doi YL, Kitaoka H (2020) Lifelong clinical impact of the presence of sarcomere gene mutation in Japanese patients with hypertrophic cardiomyopathy. Circ J 84:1846–1853

Article  CAS  PubMed  Google Scholar 

Zheng X, Yang B, Hui H, Lu B, Feng Y (2022) Alcohol septal ablation or septal myectomy? An updated systematic review and meta-analysis of septal reduction therapy for hypertrophic obstructive cardiomyopathy. Front Cardiovasc Med 9:900469

Article  PubMed  PubMed Central  Google Scholar 

Sorajja P, Valeti U, Nishimura RA, Ommen SR, Rihal CS, Gersh BJ, Hodge DO, Schaff HV, Holmes DR (2008) Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation 118:131–139

Article  PubMed  Google Scholar 

Jensen MK, Almaas VM, Jacobsson L, Hansen PR, Havndrup O, Aakhus S, Svane B, Hansen TF, Køber L, Endresen K, Eriksson MJ, Jørgensen E, Amlie JP, Gadler F, Bundgaard H (2011) Long-term outcome of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: a scandinavian multicenter study. Circ Cardiovasc Interv 4:256–265

Article  PubMed  Google Scholar 

Batzner A, Pfeiffer B, Neugebauer A, Aicha D, Blank C, Seggewiss H (2018) Survival after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 72:3087–3094

Article  PubMed  Google Scholar 

Nguyen A, Schaff HV, Hang D, Nishimura RA, Geske JB, Dearani JA, Lahr BD, Ommen SR (2019) Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: a propensity score-matched cohort. J Thorac Cardiovasc Surg 157:306-315.e3

Article  PubMed  Google Scholar 

Mestres CA, Bartel T, Sorgente A, Müller S, Gruner C, Dearani J, Quintana E (2018) Hypertrophic obstructive cardiomyopathy: what, when, why, for whom? Eur J Cardiothorac Surg 53:700–707

Article  PubMed  Google Scholar 

Veselka J, Faber L, Liebregts M, Cooper R, Januska J, Kashtanov M, Dabrowski M, Hansen PR, Seggewiss H, Hansvenclova E, Bundgaard H, Ten Berg J, Stables RH, Jensen MK (2019) Short- and long-term outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with mild left ventricular hypertrophy: a propensity score matching analysis. Eur Heart J 40:1681–1687

Article  PubMed  Google Scholar 

Hiruma T, Kitamura M, Takamisawa I, Izumi Y, Higuchi R, Nanasato M, Shimokawa T, Takanashi S, Isobe M, Takayama M (2024) Predictors of repeated septal reduction after alcohol septal ablation in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 83:546–548

Article  CAS  PubMed  Google Scholar